Immuron IMRN
NASDAQ IMRN
$1.12 -0.06 (-5.08%)
As of: Aug 21, 2026 · 3:58 PM EDT

Immuron (IMRN) Short-term Investments (2023)

Immuron (IMRN) posted quarterly Short-term Investments of $1.2 million for Q4 2023, down 1.67% quarter-over-quarter from $1.2 million in Q2 2023.

Immuron (IMRN) Short-term Investments (2023) Analysis & Trends

Immuron's Short-term Investments history runs 1 years deep, the most recent figure standing at $1.2 million for Q4 2023.

  • In Q4 2023, Short-term Investments changed N/A year-over-year to $1.2 million; the TTM figure through Dec 2023 stood at $1.2 million (changed N/A YoY), while the FY2023 annual figure was $1.2 million, changed N/A from the prior year.
  • Short-term Investments for Q4 2023 stood at $1.2 million, down from $1.2 million in the prior quarter.
  • The five-year high for Short-term Investments was $1.2 million in Q2 2023, with the low at $1.2 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Immuron 6.75 Mn 6.73 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 1.21 Mn
Jun 30, 2023 1.23 Mn